Multaq 400 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26F6BZ9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,158
Award facts
- Contract value 100% obligated
- $10,158.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Multaq (dronedarone) 400 mg tablets in quantities of 60 units, valued at $10,158.39. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The performance location is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary distribution hub for federal pharmaceutical procurement. The contract has an ultimate completion date of November 13, 2025, reflecting the delivery order's immediate fulfillment requirements.
This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a premier pharmaceutical distributor, AmerisourceBergen serves critical federal medical supply needs across the Defense Health Agency and broader military healthcare systems. The Multaq delivery supports cardiovascular treatment protocols within military and veteran healthcare programs, representing one of numerous pharmaceutical deliveries executed through the company's comprehensive federal contract vehicle that encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F6BZ9?
SPE2DR26F6BZ9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26F6BZ9 worth?
The government has obligated $10,158 on SPE2DR26F6BZ9.
Is contract SPE2DR26F6BZ9 an order under another contract?
Yes. SPE2DR26F6BZ9 is a delivery order under SPE2DR25D1052, an indefinite delivery contract.
Was contract SPE2DR26F6BZ9 competed?
The extent of competition for SPE2DR26F6BZ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award